Login / Signup

CETP inhibition improves the lipid profile but has no effect on clinical cardiovascular outcomes in high-risk patients.

Robert S Rosenson
Published in: Evidence-based medicine (2017)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • patient reported outcomes